Search research articles
Contact Us
Filters
Showing results (1-10 of 250) with videos related to
Page
of 25
Sort By:
European Journal of Immunology
|
April 26, 2012
Taurine: energy drink for T cells
Martin F Bachmann
Immunotherapy
|
July 20, 2010
Immunodrugs: breaking B- but not T-cell tolerance with therapeutic anticytokine vaccines
Alexander Link, Martin F Bachmann
Journal of Immunology (Baltimore, Md. : 1950)
|
May 7, 2004
Loading of MHC class I and II presentation pathways by exogenous antigens: a quantitative in vivo comparison
Tazio Storni, Martin F Bachmann
Vaccine
|
February 19, 2013
Active immunotherapy for chronic diseases
Martin F Bachmann, Piers Whitehead
Expert Review of Vaccines
|
February 7, 2008
Exploiting viral properties for the rational design of modern vaccines
Gunther Spohn, Martin F Bachmann
EMBO Reports
|
December 7, 2007
Interleukin 2: from immunostimulation to immunoregulation and back again
Martin F Bachmann, Annette Oxenius
Current Topics in Microbiology and Immunology
|
March 29, 2019
Immunogenicity and Immunodominance in Antibody Responses
Monique Vogel, Martin F Bachmann
Cellular Immunology
|
December 4, 2003
On the role of APC-activation for in vitro versus in vivo T cell priming
Tazio Storni, Martin F Bachmann
Critical Reviews in Immunology
|
September 20, 2005
Function of marginal zone B cells in antiviral B-cell responses
Dominique Gatto, Martin F Bachmann
Current Opinion in Molecular Therapeutics
|
March 2, 2006
Therapeutic vaccines for nicotine dependence
Patrik Maurer, Martin F Bachmann
Page
of 25
Search research articles
Search
Showing results (1-10 of 250) with videos related to
Sort By:
Page
of 25
European Journal of Immunology
|
April 26, 2012
Taurine: energy drink for T cells
Martin F Bachmann
Immunotherapy
|
July 20, 2010
Immunodrugs: breaking B- but not T-cell tolerance with therapeutic anticytokine vaccines
Alexander Link, Martin F Bachmann
Journal of Immunology (Baltimore, Md. : 1950)
|
May 7, 2004
Loading of MHC class I and II presentation pathways by exogenous antigens: a quantitative in vivo comparison
Tazio Storni, Martin F Bachmann
Vaccine
|
February 19, 2013
Active immunotherapy for chronic diseases
Martin F Bachmann, Piers Whitehead
Expert Review of Vaccines
|
February 7, 2008
Exploiting viral properties for the rational design of modern vaccines
Gunther Spohn, Martin F Bachmann
EMBO Reports
|
December 7, 2007
Interleukin 2: from immunostimulation to immunoregulation and back again
Martin F Bachmann, Annette Oxenius
Current Topics in Microbiology and Immunology
|
March 29, 2019
Immunogenicity and Immunodominance in Antibody Responses
Monique Vogel, Martin F Bachmann
Cellular Immunology
|
December 4, 2003
On the role of APC-activation for in vitro versus in vivo T cell priming
Tazio Storni, Martin F Bachmann
Critical Reviews in Immunology
|
September 20, 2005
Function of marginal zone B cells in antiviral B-cell responses
Dominique Gatto, Martin F Bachmann
Current Opinion in Molecular Therapeutics
|
March 2, 2006
Therapeutic vaccines for nicotine dependence
Patrik Maurer, Martin F Bachmann
Page
of 25